Diabetic neuropathy is one of the most common chronic complications, and its frequency varies by sociodemographic context, affecting older adults especially. The most recent reviews agree that primary prevention remains the most effective strategy.
That prevention rests on strict glycemic control combined with comprehensive management of other cardiovascular risk factors, such as high blood pressure or elevated cholesterol, rather than treatments applied once nerve damage has already occurred.
At the same time, the development of new drug treatments and neuromodulation techniques opens a promising outlook for improving the prognosis of people already living with this complication.